Company* |
Company |
Type/Product Area | Terms/Details (Date) |
Angiotech |
Edwards Lifesciences Corp. (NYSE:EW) |
Agreement regarding the distribution of Angiotech's Vascular Wrap paclitaxel-eluting mesh/ePTFE graft combination product |
Angiotech now has the exclusive rights to distribute the product through its own sales force and distribution network in Europe (5/10) |
Cronos |
Cancer Research Technology Ltd.* (UK) |
Extended agreement that allows for the addition of three new potential GeneICE compounds to the collaboration |
The agreement originally focused on one compound and its potential in halting the development and growth of cancerous cells by preventing the transcription of specific genes involved in tumorigenesis (5/14) |
Evotec AG |
Panacos Pharmaceuticals Inc.(PANC) |
Extended ongoing discovery collaboration with Evotec into its fourth year |
Evotec has supported Panacos since 2004 in identifying novel compounds for treating viral infection (5/10) |
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, stock symbols listed are on the Nasdaq market. | |||
FSE = Frankfurt Stock Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange. |